搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Staphylococcus aureus Translation initiation factor IF-1 (infA) CSB-YP641934SKZ
CSB-EP641934SKZ
CSB-BP641934SKZ
CSB-MP641934SKZ
CSB-EP641934SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Energy-coupling factor transporter ATP-binding protein EcfA 1 (ecfA1) CSB-YP641935SKZ
CSB-EP641935SKZ
CSB-BP641935SKZ
CSB-MP641935SKZ
CSB-EP641935SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Tagatose 1,6-diphosphate aldolase (lacD) CSB-YP641936SKZ
CSB-EP641936SKZ
CSB-BP641936SKZ
CSB-MP641936SKZ
CSB-EP641936SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus S-ribosylhomocysteine lyase (luxS) CSB-YP641937SKZ
CSB-EP641937SKZ
CSB-BP641937SKZ
CSB-MP641937SKZ
CSB-EP641937SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Thymidine kinase (tdk) CSB-YP641938SKZ
CSB-EP641938SKZ
CSB-BP641938SKZ
CSB-MP641938SKZ
CSB-EP641938SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus ATP synthase subunit c (atpE), partial CSB-YP641939SKZ1
CSB-EP641939SKZ1
CSB-BP641939SKZ1
CSB-MP641939SKZ1
CSB-EP641939SKZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase (fabZ) CSB-YP641940SKZ
CSB-EP641940SKZ
CSB-BP641940SKZ
CSB-MP641940SKZ
CSB-EP641940SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Potassium-transporting ATPase A chain (kdpA), partial CSB-YP641941SKZ
CSB-EP641941SKZ
CSB-BP641941SKZ
CSB-MP641941SKZ
CSB-EP641941SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 3-isopropylmalate dehydrogenase (leuB) CSB-YP641942SKZ
CSB-EP641942SKZ
CSB-BP641942SKZ
CSB-MP641942SKZ
CSB-EP641942SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 60 kDa chaperonin (groL), partial CSB-YP641943SKZ
CSB-EP641943SKZ
CSB-BP641943SKZ
CSB-MP641943SKZ
CSB-EP641943SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus NH (3)-dependent NAD (+) synthetase (nadE) CSB-YP641944SKZ
CSB-EP641944SKZ
CSB-BP641944SKZ
CSB-MP641944SKZ
CSB-EP641944SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA) CSB-YP641945SKZ
CSB-EP641945SKZ
CSB-BP641945SKZ
CSB-MP641945SKZ
CSB-EP641945SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Regulatory protein recX (recX) CSB-YP641946SKZ
CSB-EP641946SKZ
CSB-BP641946SKZ
CSB-MP641946SKZ
CSB-EP641946SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Signal transduction protein TRAP (traP) CSB-YP641947SKZ
CSB-EP641947SKZ
CSB-BP641947SKZ
CSB-MP641947SKZ
CSB-EP641947SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 2-succinylbenzoate--CoA ligase (menE) CSB-YP641948SKZ
CSB-EP641948SKZ
CSB-BP641948SKZ
CSB-MP641948SKZ
CSB-EP641948SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Leucine--tRNA ligase (leuS), partial CSB-YP641949SKZ
CSB-EP641949SKZ
CSB-BP641949SKZ
CSB-MP641949SKZ
CSB-EP641949SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Iron-regulated surface determinant protein H (isdH), partial CSB-YP641950SKZ
CSB-EP641950SKZ
CSB-BP641950SKZ
CSB-MP641950SKZ
CSB-EP641950SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Alanine dehydrogenase 2 (ald2) CSB-YP641951SKZ
CSB-EP641951SKZ
CSB-BP641951SKZ
CSB-MP641951SKZ
CSB-EP641951SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Threonine--tRNA ligase (thrS), partial CSB-YP641952SKZ
CSB-EP641952SKZ
CSB-BP641952SKZ
CSB-MP641952SKZ
CSB-EP641952SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Porphobilinogen deaminase (hemC) CSB-YP641953SKZ
CSB-EP641953SKZ
CSB-BP641953SKZ
CSB-MP641953SKZ
CSB-EP641953SKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>